2025
Advancements in minimally invasive interventional oncology procedures for painful sacral metastases under imaging guidance
Jiang W, Gan D, Johnson M, Latich I, Lee F. Advancements in minimally invasive interventional oncology procedures for painful sacral metastases under imaging guidance. EngMedicine 2025, 2: 100051. DOI: 10.1016/j.engmed.2024.100051.Peer-Reviewed Original ResearchPainful sacral metastasesIntra-operative image guidanceSacral metastasesImage guidancePreoperative baselineFollow-upPercutaneous interventionFunction scoresLong-term follow-upRisk of cement leakageO-arm navigationImprovement of painRetrospective cohort reviewImage guidance techniquesAverage follow-upInterventional oncology proceduresIntra-operative imaging techniquesO-armPercutaneous ablationSingle-institutionCohort reviewPrimary cancerClinical improvementMultiple myelomaCement leakage
2024
An Interventional Radiologist's Guide to Lung Cancer
Fish A, Madoff D. An Interventional Radiologist's Guide to Lung Cancer. Seminars In Interventional Radiology 2024, 41: 121-128. PMID: 38993601, PMCID: PMC11236454, DOI: 10.1055/s-0044-1786725.Peer-Reviewed Original ResearchLung cancer patientsLung cancerTissue diagnosisInterventional radiologistsCancer patientsField of interventional oncologyTreating lung cancer patientsTreatment of lung cancerEarly-stage diseaseAdvanced medical therapiesLung cancer complicationsBiopsy complicationsRadiation therapyPercutaneous ablationSurgical therapyMedical therapyInterventional oncologyEndovascular therapyInvasive treatmentCancer complicationsCancer deathTherapyGold standardCancerTreatment pathways
2023
Percutaneous Ablation, Osteoplasty, Reinforcement, and Internal Fixation for Pain and Ambulatory Function in Periacetabular Osteolytic Malignancies.
Dussik C, Toombs C, Alder K, Yu K, Berson E, Ibe I, Li F, Lindskog D, Friedlaender G, Latich I, Lee F. Percutaneous Ablation, Osteoplasty, Reinforcement, and Internal Fixation for Pain and Ambulatory Function in Periacetabular Osteolytic Malignancies. Radiology 2023, 307: e221401. PMID: 36916888, DOI: 10.1148/radiol.221401.Peer-Reviewed Original ResearchConceptsOsteolytic neoplasmAmbulatory functionInternal fixationEastern Cooperative Oncology Group scoreIndex scoreConversion hip arthroplastyRetrospective observational studySurgical site infectionKaplan-Meier analysisLong-term painQuality of lifeLong-term improvementWilcoxon signed-rank testNonambulatory patientsSecondary outcomesPrimary outcomeSite infectionOncologic careECOG scorePercutaneous ablationPeriacetabular metastasisProtrusio acetabuliFunctional improvementSigned-rank testClinical data
2021
A Novel Treatment for Metastatic Serous Cystadenocarcinoma Using a Microwave Ablation: Case Report and Review of the Literature.
Murtha TD, Cornman-Homonoff J, Ayyagari R, Zhang X, Salem RR. A Novel Treatment for Metastatic Serous Cystadenocarcinoma Using a Microwave Ablation: Case Report and Review of the Literature. Pancreas 2021, 50: 434-440. PMID: 33835976, DOI: 10.1097/mpa.0000000000001785.Peer-Reviewed Case Reports and Technical NotesConceptsSerous cystadenocarcinomaSerous cystadenomaMicrowave ablationRecurrence 3 yearsSolitary hepatic metastasisEffective treatment optionPercutaneous microwave ablationPancreatic cystic neoplasmsRare malignant variantDistal pancreatectomyHepatic metastasesPatient factorsPercutaneous ablationCystic neoplasmsTreatment optionsCase reportMetastatic spreadMalignant variantAbdominal visceraLocal invasionNovel treatmentsCystadenomaHepatic implantsAdjacent structuresCystadenocarcinoma
2020
Percutaneous Ablation of Intrathoracic Malignancy
Thakore S, Perez Lozada J. Percutaneous Ablation of Intrathoracic Malignancy. Current Pulmonology Reports 2020, 9: 171-180. DOI: 10.1007/s13665-020-00262-y.Peer-Reviewed Original ResearchStereotactic body radiotherapyPercutaneous ablationImage-guided percutaneous ablationNumber one cancer killerDifferent side effect profilesComparable overall survivalPost-ablation complicationsEarly-stage diseaseSide effect profilePercutaneous ablative therapiesPalliative intentReviewLung cancerMost patientsOverall survivalSublobar resectionSurgical resectionThoracic malignanciesClinical outcomesEffect profileIntrathoracic malignanciesAblative therapyBody radiotherapyLung cancerRadiofrequency ablationAblative techniques
2018
Locoregional Therapies in the Management of Hepatocellular Carcinoma
Levey A, Ermentrout R, Bercu Z, Kies D. Locoregional Therapies in the Management of Hepatocellular Carcinoma. 2018, 57-72. DOI: 10.1007/978-3-319-91977-5_5.Peer-Reviewed Original ResearchHepatocellular carcinomaLocoregional therapyLiver functionConcomitant chronic liver diseaseImage-guided percutaneous ablationLiver diseaseManagement of hepatocellular carcinomaPatient's liver functionPrimary liver malignancyDevelopment of hepatocellular carcinomaIntrinsic liver diseaseManagement of patientsCancer-related deathsChronic liver diseaseUnresectable diseasePercutaneous ablationPerformance statusRare causeLiver malignanciesBiliary cirrhosisViral hepatitisAlcoholic cirrhosisTreatment optionsTumor therapyPatients
2012
Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors
Gaujoux S, Gonen M, Tang L, Klimstra D, Brennan M, D’Angelica M, DeMatteo R, Allen P, Jarnagin W, Fong Y. Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors. Annals Of Surgical Oncology 2012, 19: 4270-4277. PMID: 22752376, DOI: 10.1245/s10434-012-2462-8.Peer-Reviewed Original ResearchConceptsNeuroendocrine tumorsLiver metastasesSynchronous resectionSimultaneous resection of liver metastasesResection of liver metastasesRecurrent neuroendocrine tumorLiver-directed therapiesMetastatic neuroendocrine tumorsLiver metastasis resectionPrimary neuroendocrine tumorsMedian follow-upSymptom-free survivalLong-term outcomesMedian sizePrimary/recurrent tumorMetastasis resectionSimultaneous resectionLocal recurrenceTumor characteristicsOverall survivalArtery embolizationPancreatic resectionPercutaneous ablationBilobar distributionPostoperative deaths
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply